AIRLINK 191.00 Decreased By ▼ -2.50 (-1.29%)
BOP 9.75 Increased By ▲ 0.11 (1.14%)
CNERGY 7.61 Increased By ▲ 0.08 (1.06%)
FCCL 37.57 Decreased By ▼ -0.13 (-0.34%)
FFL 15.58 Decreased By ▼ -0.02 (-0.13%)
FLYNG 25.79 Increased By ▲ 0.20 (0.78%)
HUBC 129.01 Increased By ▲ 1.94 (1.53%)
HUMNL 13.50 No Change ▼ 0.00 (0%)
KEL 4.67 Increased By ▲ 0.09 (1.97%)
KOSM 6.24 Increased By ▲ 0.14 (2.3%)
MLCF 43.95 Decreased By ▼ -0.01 (-0.02%)
OGDC 204.50 Increased By ▲ 1.26 (0.62%)
PACE 6.46 Increased By ▲ 0.06 (0.94%)
PAEL 40.75 Decreased By ▼ -0.23 (-0.56%)
PIAHCLA 17.33 Decreased By ▼ -0.16 (-0.91%)
PIBTL 7.98 Increased By ▲ 0.32 (4.18%)
POWER 9.18 Increased By ▲ 0.10 (1.1%)
PPL 175.00 Increased By ▲ 0.75 (0.43%)
PRL 38.00 Decreased By ▼ -0.07 (-0.18%)
PTC 24.40 Increased By ▲ 0.33 (1.37%)
SEARL 106.76 Decreased By ▼ -0.48 (-0.45%)
SILK 0.99 Increased By ▲ 0.02 (2.06%)
SSGC 37.90 Increased By ▲ 1.50 (4.12%)
SYM 19.33 Increased By ▲ 0.29 (1.52%)
TELE 8.55 Increased By ▲ 0.31 (3.76%)
TPLP 12.30 Increased By ▲ 0.52 (4.41%)
TRG 66.00 Increased By ▲ 1.12 (1.73%)
WAVESAPP 12.79 Increased By ▲ 1.16 (9.97%)
WTL 1.68 No Change ▼ 0.00 (0%)
YOUW 3.93 Increased By ▲ 0.08 (2.08%)
BR100 11,817 Increased By 49.5 (0.42%)
BR30 35,257 Increased By 293 (0.84%)
KSE100 112,214 Increased By 727 (0.65%)
KSE30 35,177 Increased By 242.8 (0.7%)
World

EU regulator 'convinced' AstraZeneca jab benefits outweigh risks

  • The suspensions have provoked intense debate over whether it was prudent to put AstraZeneca inoculations on hold just as vaccination campaigns were beginning to gather pace.
Published March 17, 2021

THE HAGUE: The EU's medicines regulator said Tuesday it was "firmly convinced" the benefits of AstraZeneca's vaccine outweigh potential risks, insisting there was no evidence linking it to blood clots after several nations suspended the shot over health fears.

The suspensions have provoked intense debate over whether it was prudent to put AstraZeneca inoculations on hold just as vaccination campaigns were beginning to gather pace.

Experts at both the World Health Organization and the European Medicines Agency (EMA) met Tuesday to discuss the vaccine, with the European organisation expected to publish conclusions Thursday.

While millions of doses of the vaccine developed with Oxford University have been administered, small numbers of people have developed blood clots, prompting countries including the EU's three largest nations -- Germany, France and Italy -- to suspend injections.

The EMA insisted that countries should continue using the vaccine.

"We are still firmly convinced that the benefits of the AstraZeneca vaccine in preventing Covid-19 with its associated risk of hospitalisation and death outweigh the risk of these side effects," EMA chief Emer Cooke said Tuesday.

Cooke noted however that the regulator was "looking at adverse events associated with all vaccines".

France and Italy welcomed the news.

The preliminary statements from the EMA "are encouraging," read a joint statement from French President Emmanuel Macron and Italian Prime Minister Mario Draghi.

French Prime Minister Jean Castex vowed he would be vaccinated "very quickly" with the AstraZeneca vaccine to give the public confidence in the jab if it is ruled as safe by the EU medicines agency.

Castex also said that new restrictions could be put in place for the Paris region, such as the weekend lockdowns already imposed in the Nice and Calais regions.

"We are in a worrying and critical situation and, clearly, measures of the type that have been used in other parts of the territory are on the table," he told BFM TV in a live interview.

Comments

Comments are closed.